Literature DB >> 35702076

Application value of whole-course health management for patients with nonvalvular atrial fibrillation with oral warfarin treatment.

Min Zhang1, Jianjing Chen1, Chunmei Gao1, Shunzhong Gu1, Ping Yang2, Zhenlan Xu1.   

Abstract

OBJECTIVE: To explore the effect of the whole-process health management model on the compliance of oral warfarin treatment in patients with non-valvular atrial fibrillation in primary hospitals.
METHODS: We retrospectively analyzed the clinical data of 130 patients with non-valvular atrial fibrillation treated in the Department of Cardiovascular Medicine, Hai'an People's Hospital from January 2019 to December 2019. Among them, 63 patients who received routine continuing care were included in the control group, and 67 patients treated with whole-course health management model of primary hospitals were included in the observation group. The two groups were compared in terms of the following parameters: Warfarin anticoagulation knowledge, medication compliance, compliance rate (international normalized ratio, INR) monitoring, bleeding events (gingival bleeding, subcutaneous bleeding, gastrointestinal bleeding, etc.), embolic events (vascular thrombosis), negative emotions before and after management, and patient satisfaction. Logistic analysis was used to analyze independent risk factors affecting the effect of warfarin anticoagulation in patients with non-valvular atrial fibrillation.
RESULTS: Compared with the control group, the warfarin anticoagulation knowledge, medication compliance, and INR compliance rate of the observation group were significantly higher, and the incidence of adverse events was significantly lower. Self-rating Anxiety Scale (SAS) and Self-rating Depression Scale (SDS) scores were not significantly different between the two groups before management. After management, SAS and SDS scores decreased significantly in both groups, and were lower in the observation group compared with the control group. The management satisfaction was also significantly higher in the observation group.
CONCLUSION: Compared with the conventional continuation care model, the whole-process management in primary hospitals can improve patients' compliance with medical advice and treatment efficacy, with lower risk of bleeding and higher patient satisfaction, providing a better option for the out-of-hospital management of anticoagulation for non-valvular atrial fibrillation patients. Age, hypertension, diabetes, knowledge of warfarin anticoagulation and medication compliance were independent risk factors for the effect of warfarin anticoagulation in patients with non-valvular atrial fibrillation. AJTR
Copyright © 2022.

Entities:  

Keywords:  Primary hospital whole-course health management model; compliance; non-valvular atrial fibrillation; warfarin

Year:  2022        PMID: 35702076      PMCID: PMC9185060     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   3.940


  24 in total

Review 1.  Left Atrial Appendage Occlusion for The Unmet Clinical Needs of Stroke Prevention in Nonvalvular Atrial Fibrillation.

Authors:  David R Holmes; Mohamad Alkhouli; Vivek Reddy
Journal:  Mayo Clin Proc       Date:  2019-04-05       Impact factor: 7.616

Review 2.  New Findings in Atrial Fibrillation Mechanisms.

Authors:  Dennis H Lau; Dominik Linz; Prashanthan Sanders
Journal:  Card Electrophysiol Clin       Date:  2019-12

3.  Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation.

Authors:  So-Ryoung Lee; Eue-Keun Choi; Soonil Kwon; Kyung-Do Han; Jin-Hyung Jung; Myung-Jin Cha; Seil Oh; Gregory Y H Lip
Journal:  Stroke       Date:  2019-06-18       Impact factor: 7.914

4.  Factors influencing dabigatran or warfarin medication persistence in patients with nonvalvular atrial fibrillation.

Authors:  Srinivas Annavarapu; Pranav K Gandhi; Yong Li; Prachi Arora; Chad Moretz; Cheng Wang; Stephen D Sander; George A Andrews
Journal:  J Comp Eff Res       Date:  2018-05-29       Impact factor: 1.744

5.  Comparison of Hospital Anxiety and Depression Scale (HADS) and Zung Self-Rating Anxiety/Depression Scale (SAS/SDS) in Evaluating Anxiety and Depression in Patients with Psoriatic Arthritis.

Authors:  Tao Yue; Qiting Li; Rongsheng Wang; Zhaoyi Liu; Mengru Guo; Fengmin Bai; Zhanming Zhang; Weifeng Wang; Yahui Cheng; Haijun Wang
Journal:  Dermatology       Date:  2019-08-21       Impact factor: 5.366

6.  Effect of anxiety and depression on the recurrence of persistent atrial fibrillation after circumferential pulmonary vein ablation.

Authors:  Sheng-bo Yu; Wei Hu; Qing-yan Zhao; Mu Qin; He Huang; Hong-ying Cui; Cong-xin Huang
Journal:  Chin Med J (Engl)       Date:  2012-12       Impact factor: 2.628

7.  Factors influencing medication knowledge and beliefs on warfarin adherence among patients with atrial fibrillation in China.

Authors:  Shujuan Zhao; Hongwei Zhao; Xianpei Wang; Chuanyu Gao; Yuhua Qin; Haixia Cai; Boya Chen; Jingjing Cao
Journal:  Patient Prefer Adherence       Date:  2017-02-09       Impact factor: 2.711

8.  Association between use of amiodarone for non-valvular atrial fibrillation and patient survival: from the prospective China Atrial Fibrillation Registry.

Authors:  Xiao-Xia Hou; Liu He; Xin Du; Guo-Hong Wang; Jian-Zeng Dong; Chang-Sheng Ma
Journal:  Chin Med J (Engl)       Date:  2020-12-01       Impact factor: 2.628

Review 9.  Risk of atrial fibrillation in athletes: a systematic review and meta-analysis.

Authors:  William Newman; Gemma Parry-Williams; Jonathan Wiles; Jamie Edwards; Sabina Hulbert; Konstantina Kipourou; Michael Papadakis; Rajan Sharma; Jamie O'Driscoll
Journal:  Br J Sports Med       Date:  2021-07-12       Impact factor: 13.800

10.  Dialysis Mode and Associated Outcomes in Patients With End-Stage Renal Disease and Atrial Fibrillation: A 14-Year Nationwide Cohort Study.

Authors:  Chih-Hsiang Chang; Pei-Chun Fan; Yu-Sheng Lin; Shao-Wei Chen; Michael Wu; Ming-Shyan Lin; Cheng-Hui Lu; Po-Cheng Chang; Ming-Jer Hsieh; Chao-Yung Wang; Chun-Li Wang; Pao-Hsien Chu; Victor Chien-Chia Wu
Journal:  J Am Heart Assoc       Date:  2021-06-02       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.